Aarkstore - Epstein-Barr Viral Infections - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Epstein-Barr Viral Infections - Pipeline Review, H2 2014 PowerPoint presentation | free to download - id: 7350e1-MmRiN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Epstein-Barr Viral Infections - Pipeline Review, H2 2014

Description:

“Epstein-Barr Viral Infections - Pipeline Review, H2 2014”, provides an overview of the Epstein-Barr Viral Infectionss therapeutic pipeline. For more details : – PowerPoint PPT presentation

Number of Views:14

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Epstein-Barr Viral Infections - Pipeline Review, H2 2014


1
Aarkstore - Epstein-Barr Viral Infections -
Pipeline Review, H2 2014
www.aarkstore.com
2
Summary
  • Epstein-Barr Viral Infections - Pipeline Review,
    H2 2014, provides an overview of
  • the Epstein-Barr Viral Infectionss therapeutic
    pipeline.
  • This Market Research Report provides
    comprehensive information on the therapeutic
  • development for Epstein-Barr Viral Infections,
    complete with comparative analysis at various
  • stages, therapeutics assessment by drug target,
    mechanism of action (MoA), route of
  • administration (RoA) and molecule type, along
    with latest updates, and featured news and
  • press releases. It also reviews key players
    involved in the therapeutic development for
  • Epstein-Barr Viral Infections and special
    features on late-stage and discontinued
    projects.

www.aarkstore.com
www.aarkstore.com
3
Scope
  • - The report provides a snapshot of the
    global therapeutic landscape of Epstein-Barr
    Viral Infections- The report reviews key
    pipeline products under drug profile section
    which includes, product description, MoA and RD
    brief, licensing and collaboration details
    other developmental activities - The report
    reviews key players involved in the therapeutics
    development for Epstein-Barr Viral Infections and
    enlists all their major and minor projects- The
    report summarizes all the dormant and
    discontinued pipeline projects - A review of the
    Epstein-Barr Viral Infections products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources- Pipeline
    products coverage based on various stages of
    development ranging from pre-registration till
    discovery and undisclosed stages- A detailed
    assessment of monotherapy and combination therapy
    pipeline projects- Coverage of the Epstein-Barr
    Viral Infections pipeline on the basis of target,
    MoA, route of administration and molecule type-
    Latest news and deals relating related to
    pipeline products

www.aarkstore.com
www.aarkstore.com
4
Reasons to buy
  • - Provides strategically significant
    competitor information, analysis, and insights to
    formulate effective RD development strategies-
    Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive
    advantage- Develop strategic initiatives by
    understanding the focus areas of leading
    companies- Identify and understand important and
    diverse types of therapeutics under development
    for Epstein-Barr Viral Infections- Plan mergers
    and acquisitions effectively by identifying key
    players of the most promising pipeline- Devise
    corrective measures for pipeline projects by
    understanding Epstein-Barr Viral Infections
    pipeline depth and focus of Indication
    therapeutics- Develop and design in-licensing
    and out-licensing strategies by identifying
    prospective partners with the most attractive
    projects to enhance and expand business potential
    and Scope- Modify the therapeutic portfolio by
    identifying discontinued projects and
    understanding the factors that drove them from
    pipeline

www.aarkstore.com
www.aarkstore.com
5
Table of Contents
  • Introduction 6Global Markets Direct
    Report Coverage 6Epstein-Barr Viral Infections
    Overview 7Therapeutics Development 8Pipeline
    Products for Epstein-Barr Viral Infections -
    Overview 8Pipeline Products for Epstein-Barr
    Viral Infections - Comparative Analysis
    9Epstein-Barr Viral Infections - Therapeutics
    under Development by Companies 10Epstein-Barr
    Viral Infections - Therapeutics under
    Investigation by Universities/Institutes
    11Epstein-Barr Viral Infections - Pipeline
    Products Glance 13Clinical Stage Products
    13Early Stage Products 14Epstein-Barr Viral
    Infections - Products under Development by
    Companies 15Epstein-Barr Viral Infections -
    Products under Investigation by
    Universities/Institutes 16

www.aarkstore.com
www.aarkstore.com
6
List Of Tables
  • Number of Products under Development for
    Epstein-Barr Viral Infections, H2 2014 8Number
    of Products under Development for Epstein-Barr
    Viral Infections - Comparative Analysis, H2 2014
    9Number of Products under Development by
    Companies, H2 2014 10Number of Products under
    Investigation by Universities/Institutes, H2 2014
    12Comparative Analysis by Clinical Stage
    Development, H2 2014 13Comparative Analysis by
    Early Stage Development, H2 2014 14Products
    under Development by Companies, H2 2014
    15Products under Investigation by
    Universities/Institutes, H2 2014 16Epstein-Barr
    Viral Infections - Pipeline by Cell Medica
    Limited, H2 2014 17Epstein-Barr Viral Infections
    - Pipeline by Conkwest, Inc., H2 2014
    18

www.aarkstore.com
7
List Of Figures
  • Number of Products under Development for
    Epstein-Barr Viral Infections, H2 2014Number of
    Products under Development for Epstein-Barr Viral
    Infections - Comparative Analysis, H2 2014Number
    of Products under Development by Companies, H2
    2014 Number of Products under Investigation by
    Universities/Institutes, H2 2014 Comparative
    Analysis by Clinical Stage Development, H2 2014
    Comparative Analysis by Early Stage Products, H2
    2014 Assessment by Monotherapy Products, H2 2014
    Number of Products by Top 10 Targets, H2 2014
    Number of Products by Stage and Top 10 Targets,
    H2 2014 Number of Products by Top 10 Mechanism
    of Actions, H2 2014

www.aarkstore.com
8
Related Market Research reports
  • Blirt S.A. - Product Pipeline Review 2014
  • Auris Medical Holding AG - Product Pipeline
    Review 2014
  • Integral Molecular, Inc. - Product Pipeline
    Review 2014
  • DaVinci Biosciences, LLC - Product Pipeline
    Review 2014
  • Actavis plc - Product Pipeline Review - 2014

www.aarkstore.com
9
Related Market Research reports
  • TiGenix NV - Product Pipeline Review 2014
  • Egenix, Inc. - Product Pipeline Review 2014
  • SkyePharma PLC - Product Pipeline Review 2014
  • MediWound Ltd. - Product Pipeline Review 2014
  • BioTech Tools s.a. - Product Pipeline Review -
    2014

www.aarkstore.com
10
Aarkstore - Epstein-Barr Viral Infections -
Pipeline Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog http//www.aarkstore.com/blog/
  • Conference http//conference.aarkstore.com/
  • News http//www.aarkstore.com/news

www.aarkstore.com
About PowerShow.com